€1.84 billionTotal budget of Global Health EDCTP3
€418 millionFunding for 92 projects with clinical trials and scientific studies
€20 millionFunding for 17 projects that strengthen clinical research capacity in sub-Saharan Africa
49 members of EDCTP Association33 African and 16 European countries
406 participating entitiesfrom 64 countries
33 SMEsparticipating in projects
Our projects

Understanding mpox virus infectionsThe MOVIE-TRACE project is clarifying two key aspects of mpox infections: the speed at which the virus is cleared from the body and its infectiousness.

Field-testing moxidectin for river blindness controlThe EMINENCE project is exploring whether a newly developed drug, moxidectin, could accelerate the elimination of onchocerciasis (river...

Advancing monoclonal antibodies to treat HIV in infantsThe ENABLE project is assessing whether broadly neutralising antibodies could make the HIV virus undetectable in young infants.

Our overall objective is to integrate our consortium’s individual skills, capacity and innovations into advanced, low-cost and deployable digital dashboards and diagnostics to understand how...

Standardised tracking of malaria and tuberculosis drug resistance The PANGenS project will introduce standardised approaches for identifying malaria and TB genetic variants associated with...

The current Mpox outbreak affecting the Democratic Republic of the Congo, ongoing since 2023, has resulted in more than 19,000 causes and over 1,000 deaths, with women accounting for more...

Extending ivermectin use to young childrenThe IVM-KIDS project is developing a child-friendly formulation of ivermectin to ensure young children can benefit from this key drug for parasite...

Repurposing fusidic acid for onchocerciasis controlThe FAME project is assessing whether a repurposed antibiotic could improve control of onchocerciasis (river blindness).
Our community speaks
‘My message to any young researcher that's considering applying to EDCTP is: do it!’Catherine Hankins, Senior Fellow at the Amsterdam Institute for Global Health & Development
‘This programme facilitates collaboration between North and South and invests in innovation and development of the next generation.’John Gyapong, Vice-chairperson of the Global Health EDCTP3 Scientific Committee
‘Global Health EDCTP3 is unique in addressing the gaps: strengthening the capacity and the innovation components that are essential for the developing countries.’Eleni Aklilu, Professor of Tropical Pharmacology












